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ABSTRACT
Pro-apoptotic Bax is essential for RGC (retinal ganglion cell)
death. Gene dosage experiments in mice, yielding a single
wild-type Bax allele, indicated that genetic background was
abletoinfluencethecelldeathphenotype.DBA/2J
Bax+/2mice
exhibited complete resistance to nerve damage after 2 weeks
(similar to Bax
2/2 mice), but 129B6
Bax+/2 mice exhibited
significant cell loss (similar to wild-type mice). The different
cell death phenotype was associated with the level of Bax
expression, where 129B6 neurons had twice the level of
endogenous Bax mRNA and protein as DBA/2J neurons.
SequenceanalysisoftheBaxpromotersbetweenthesestrains
revealed a single nucleotide polymorphism (T
129B6 to C
DBA/2J)
atposition2515.A1.5-to2.5-foldincreaseintranscriptional
activity was observed from the 129B6 promoter in transient
transfection assays in a variety of cell types, including RGC5
cellsderivedfromratRGCs.Sincethispolymorphismoccurred
in a p53 half-site, we investigated the requirement of p53 for
the differential transcriptional activity. Differential transcrip-
tional activity from either 129B6 or DBA/2J Bax promoters
were unaffected in p53
2/2 cells, and addition of exogenous
p53hadnofurthereffectonthisdifference,thusaroleforp53
was excluded. Competitive electrophoretic mobility-shift
assays identified two DNA–protein complexes that interacted
withthepolymorphicregion.ThoseformingComplex1bound
withhigheraffinitytothe129B6polymorphicsite,suggesting
that these proteins probably comprised a transcriptional
activator complex. These studies implicated quantitative
expression of the Bax gene as playing a possible role in
neuronal susceptibility to damaging stimuli.
Key words: Bax, gene expression, glaucoma, neuronal
apoptosis, retinal ganglion cells, susceptibility allele.
INTRODUCTION
Neuronal apoptosis is widespread during the development of
the nervous system and in chronic neurodegenerative diseases
such as Huntington’s disease, amyotrophic lateral sclerosis,
Parkinson’sdiseaseandAlzheimer’s disease (Akhtar et al.,2004;
Kermeretal.,2004;Lindholmetal.,2004;Confortietal.,2007).
RGC(retinal ganglioncell)death,andthedegeneration oftheir
axons in the optic nerve, is the principal characteristic of
blinding optic neuropathies such as glaucoma (Nickells, 2007).
Previously we, and others, have documented an essential role
for Bax expression and the intrinsic apoptotic pathway in the
process of RGC death in development, after acute nerve
trauma and in a mouse model of chronic glaucoma (Isenmann
et al., 1997; Mosinger Ogilvie et al., 1998; Isenmann et al.,
1999; Li et al., 2000; Libby et al., 2005a).
The intrinsic apoptotic pathway involves mitochondrial
dysfunction and is regulated by members of the Bcl2 gene
family (Adams and Cory, 2007). In this pathway, the
molecular events leading to cell death cause the release of
cytochrome c through permeabilization of the mitochondria
by the pro-apoptotic proteins BAX and BAK. The release of
cytochrome c subsequently activates the caspase cascade via
its association with pro-caspase 9 and the apoptosis protease
activating factor-1 (Danial and Korsmeyer, 2004; Adams and
Cory, 2007). In most cell types, the functions of BAX and BAK
are similar, and therefore redundant with the exception of
some cancer cells (Zhang et al., 2000) and many neurons
(Knudson et al., 1995; Deckwerth et al., 1996; White et al.,
1998), in which BAX is the central mediator of apoptosis. In
neurons, the exclusive role for BAX may result from
alternative splicing of Bak transcripts, which result in the
translation of a truncated form of BAK (N-BAK) containing
only the BH3 domain (Uo et al., 2005).
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that Bax knockout mice on a mixed 129/Sv and C57BL/6
background (129B6) (Knudson et al., 1995) exhibited reduced
developmental neuronal death throughout the central and
peripheral nervous system compared with wild-type mice
(Deckwerth et al., 1996; Mosinger Ogilvie et al., 1998; White
et al., 1998). Similarly, Bax deficiency prevented sympathetic
neuron death in the absence of nerve growth factor in
culture. In vivo, Bax deficiency promoted motor neuron
survival following both facial and sciatic nerve axotomy, and
RGC survival following ONC (optic nerve crush) (Deckwerth
et al., 1996; Li et al., 2000; Sun and Oppenheim, 2003). In
Bax
+/2 mice, however, developmental apoptosis of sympath-
etic and facial motor neurons, and RGCs, was comparable
with wild-type mice. In addition, motor neuron death after
facial nerve axotomy was comparable between Bax
+/2 and
wild-type mice (Deckwerth et al., 1996; Mosinger Ogilvie
et al., 1998). Collectively, these studies suggested that
expression from a single copy of Bax was sufficient to
execute apoptosis in mice with the 129B6 mixed genetic
background.
Similar to 129B6 mice, complete Bax deficiency in the
DBA/2J mouse line prevented RGC soma death during
glaucoma and after ONC (Libby et al., 2005a). DBA/2J mice
develop chronic secondary glaucoma at 10–12 months of age
characterized by elevated intraocular pressure, optic nerve
degeneration, and the progressive loss of RGCs (Chang et al.,
1999; Libby et al., 2005b; Schlamp et al., 2006). In contrast
with 129B6 mice, however, DBA/2J mice heterozygous for the
Bax allele did not exhibit significant RGC death shortly after
ONC and in glaucoma, whereas wild-type animals did (Libby
et al., 2005a). Thus reduced Bax expression, at least on some
genetic backgrounds, was able to significantly affect RGC
soma susceptibility to optic nerve damage.
In the present study, we examine the underlying cause for
the differential cell death phenotype between 129B6 and
DBA/2J mice heterozygous for the mutant Bax allele. This
difference is associated with higher levels of latent Bax mRNA
and protein in the neurons of 129B6 mice. Promoter analysis
also identified a single nucleotide polymorphism in the Bax
promoter of each strain, which can significantly alter the
level of expression of this gene, and affect the binding
affinity of nuclear proteins.
MATERIALS AND METHODS
Animals
Mice used in the present study were maintained and handled
in accordance with the guidelines established by the
Association for Research in Vision and Ophthalmology
Statement on Animals in Research and overseen by the
Animal Care and Use Committee at the University of
Wisconsin. A colony of mice deficient for Bax (Knudson et
al., 1995) was established from breeders obtained from the
late Dr Stanley Korsmeyer and maintained as an inbred
population. In this line, the null allele was initially generated
in 129/Sv-derived embryonic stem cells, which were intro-
duced into C57BL/6 embryos. We have designated these mice
as 129B6 because of their mixed genetic background. DBA/2J
mice congenic for the Bax null allele (Libby et al., 2005a) were
generously provided by Dr Simon John (Bar Harbor, ME,
U.S.A.). FVB mice were a gift from Dr Paul Lambert (School of
Medicine and Public Health, University of Wisconsin,
Madison, WI, U.S.A.).
ONC and ganglion cell counting
ONC surgery was performed as described previously (Li et al.,
1999). ONC causes synchronous RGC death in the ganglion
cell layer, which accounts for 50–60% of the neurons in this
layer. Only the left eye of each mouse underwent surgery,
leaving the other eye as a control. The loss of cells in the
retinal ganglion cell layer was quantified as described
previously (Li et al., 2007).
Cell culture
All cells were maintained in a humidified incubator at 37˚C
with 5% CO2 and media replaced every 2–3 days. NIH 3T3 cells,
an immortalized murine fibroblast cell line, were a gift from Dr
Donna Peters (Department of Pathology and Laboratory
Medicine, University of Wisconsin, Madison, WI, U.S.A.). The
cells were grown in DMEM (Dulbecco’s modified Eagle’s
medium) containing 4.5 g/l glucose with L-glutamine
(Cambrex) supplemented with 10% FBS (fetal bovine serum)
(Atlanta Biologicals) and with 1% penicillin/streptomycin
(Cambrex). NIH3T3cells were passaged at 70–80% confluency.
RGC-5 cells (Krishnamoorthy et al., 2001), an immortalized rat
retinal ganglion cell line, were a gift from Dr Neeraj Agarwal
(Vision Research Program, National Eye Institute, Rockville,
MD, U.S.A.). RGC-5 cells were cultured in DMEM containing
10%FBS,1g/lglucoseand1%penicillin/streptomycin.Primary
lung fibroblasts from 2-month-old FVB mice (p53
+/+ and p53
2/
2 genotypes) and 3-month-old DBA/2J
Bax+/+ mice were
isolated as described previously (Konigsberg et al., 2004).
Briefly, lungs from each mouse were aseptically dissected and
minced into ,1 mm pieces. The tissue was washed three times
with PBS containing 2% penicillin/streptomycin and treated
with 0.25% trypsin for 10 min. The tissue was washed again
with PBS and treated for 5 h with 169 units/mg of 0.3%
collagenase type I (Worthington). The dissociated cells and
tissue were split into three 10-cm-diameter plates in 4.5 g/l
glucose-containing DMEM with L-glutamine, 15%FBS, and1%
penicillin/streptomycin. The resulting fibroblasts were allowed
to become confluent before being passed. Cells were
cryogenically frozen after 10 days in culture until use. All
experiments using primary fibroblasts were performed at the
third passage.
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A 3091 bp genomic fragment containing the DBA/2J or
129B6 Bax promoter region, including exon 1 and half of
intron 1, was PCR-amplified using LA Taq (Takara). The primer
sequences used were: 59-GATTAGGTTGGCTTGTTTGTGG (for-
ward) and 59-CTAGTAGTGACAAGTAGCATGG (reverse). Nhe1
and Bgl II sites were engineered into the promoter regions by
nested PCR to isolate 1370 bp directly upstream of the start
codon using the primers 59-GTGATCTTACGCTAGCTTCCTGCG-
T T C T G A G G( f o r w a r dc o n t a i n i n gN h e 1 )a n d5 9-CGAACTGTCTA-
GATCTCACTGCCGCTGCCTCTCG (reverse containing BglII). The
nucleotide directly upstream of the start codon was considered
21 and the numbering of all other nucleotides is relative to this
position. This fragment was directionally cloned into pGL3-Basic
(Promega), a Luc (luciferase) expression vector, to create the
DBA/2J–Luc and 129B6–Luc reporter constructs. The expression
plasmid containing human p53 under the control of the CMV
promoter (pC53-SN3) was a gift from Dr Mary Ellen Perry
(NationalCancerInstitute,Rockville,MD,U.S.A.)andtheplasmid
containing 13 p53 response elements (Kern et al., 1992) with a
Luc reporter (pG13-Luc) was a gift from Dr Bert Vogelstein
(Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins
University, Baltimore, MD, U.S.A.). All clones were sequenced at
the University of Wisconsin Biotechnology Center. The pGL3-
Basic plasmid was used as a negative control for Luc
experiments, pGL3-Control (Promega) was used as a positive
control, and pSV-bgal (bgal, b-galactosidase) (Promega) was
used to determine transfection efficiency.
RNA isolation and quantitative PCR
Total RNA was isolated from whole retina tissue and cultured
cells using Tri-reagent (Molecular Research Center,
Cincinnati, OH, U.S.A.). First-strand cDNA was synthesized
using oligo-dT as a primer, and quantitative PCR was
performed using the ABI (Applied Biosystems) 7300 real-time
PCR system and ABI SYBR Green PCR Master Mix as described
previously (Pelzel et al., 2006). Standard curves were
generated for each product using cloned cDNAs for Bax,
Bcl-X and the S16 ribosomal protein to quantify the
abundance of cDNA in each sample. The Bax coding region
(627 bp fragment) was isolated from DBA/2J and 129B6
retinal cDNA with the following primers: 59-ACCCGCCG-
AGAGGCAGCG (forward) and 59-CACAGTCCCAGGCAGTGGG
(reverse) and blunt-end cloned the SmaI site of pBK-CMV
(Stratagene). BclX was blunt-end cloned into pBK-CMV using
the primers 59-CATCTCACCTACCAGTCA (forward) and 59-
GTCAGAGTGGATGGTCAGT (reverse). A cDNA for S16 (199 bp
fragment) was also blunt-end cloned using 129B6 cDNA and
primers 59-CACTGCAAACGGGGAAATGG (forward) and 59-
TGAGATGGACTGTCGGATGG (reverse).
For standard curves, a dilution series of cloned Bax, Bcl-X
and S16 templates ranging from 10
2 to 10
9 copies were used.
The quantitative PCR cycling parameters were: 1 cycle of 95˚C
for 10 min, followed by 40 cycles of 95˚Cf o r1 5sa n d6 0˚Cf o r
1 min. Data collection was taken at the 60˚C annealing/
extension phase. In order to ensure the presence of a single
product,a dissociationcurve wasperformedaftereachrunand
products were visualized on ethidium bromide-stained agarose
gels. Data were collected from threshold values using the
automatic function of the 7300 System Sequence Detection
Software program. The primers used to quantify Bax cDNA
yielded a 220 bp fragment that spanned intron 3: 59-
TTCATCCAGGATCGAGCAGG (forward) and 59-CATCAGC-
AAACATGTCAGC (reverse). The primers used to quantify BclX
cDNA yielded a 275 bp fragment: 59-GCATCGTGGCC-
TTTTTCTCC (forward) and 59-CGACTGAAGAGTGAGCCCAG
(reverse). All cDNA levels were normalized to murine S16
ribosomal protein cDNA, which was quantified using the same
primers that were used to clone S16 above. All primers crossed
at least one intron/exon boundary. All PCR products generated
with these primers were also sequenced to verify identity.
Transfections
NIH 3T3 cells were plated into 60 cm plates at a density of
1610
5 cells/plate. RGC-5 cells and primary fibroblasts were
plated into six-well plates with a density of 3610
4 cells/well.
All cells were transfected 24 h after initial plating.
Transfections were performed using the Tfx-50 transfection
reagent (Promega) with a 2:1 transfection reagent/DNA ratio
for primary fibroblasts and RGC-5 cells and a 3:1 ratio for NIH
3T3 cells. Plasmid DNAs used for transfection were 2 mgo f
either DBA/2J–Luc or 129B6–Luc along with 1 mgo fp S V - bgal
to control for transfection efficiency. Empty pGL3-Basic was
used as a negative control in all experiments and pGL3-Control
was used as a positive control. For transfections into p53
2/2
fibroblasts, Luc reporter plasmids were co-transfected with
pSV-bgal and 1 mg of either pGL3-Basic or pC53-SN3 plasmids.
For primary fibroblasts and RGC-5 cells, the transfection
medium was replaced after 5 h with complete medium in order
to increase viability. In NIH 3T3 cells, however, complete
medium was added directly to the transfection medium after 1
h. Reporter gene activity was typically measured 48 h after
transfection, except where noted. Luc activity was measured
with Luc assay reagent (Promega) using a Turner TD-20e
Luminometer (Sunnyvale, CA) and b-gal activity was measured
using b-gal assay reagent (Promega) and reading the
absorbance at 420 nm in a spectrophotometer.
EMSA (electrophoretic mobility-shift assay)
EMSA and unlabelled competition EMSA were performed
using double-stranded 30 bp oligonucleotides encompassing
the polymorphic site from 2499 to 2528 of the 129B6 or
DBA/2J Bax promoters. When making probes for EMSA,
complementary strands of the 30 bp 129B6 or DBA/2J Bax
promoter regions (400 pmol) were annealed in 100 mlo f
annealing buffer (10 mM Tris/HCl, pH 7.5, and 20 mM NaCl).
The double-stranded oligonucleotides (16 pmol) were end-
labelled using [c-
32P]ATP (6000 Ci/mmol; Amersham) and T4
Polynucleotide Kinase (Promega). Free radioactivity was
Bax-dependent ganglion cell death
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89removedusingillustra
TMMicrospin G-25 Columns (Amersham).
Probes were counted in a Packard TRI CARB 2100TR liquid
scintillation analyser (Canberra, Meriden, CT, U.S.A.). NIH 3T3
nuclear extract was purchased from Santa Cruz Biotechnology.
Whole retinal nuclear protein isolations were performed as
described previously (Andrews and Faller, 1991). Nuclear
extracts (5mg) were incubatedfor10 minat room temperature
(22˚C)withbindingbuffer[5mMMgCl2, 2.5 mMEDTA,2.5mM
DTT (dithiothreitol), 250 mM NaCl and 50 mM Tris/HCl, pH 7.5]
and 3 mg of dI-dC (Amersham) per lane. A
32P-labelled probe
(600000 c.p.m./lane; ,0.12 pmol) was then added in the
presence of excess (6.25- to 150-fold where noted) or absence
of unlabelled competitor oligonucleotides and incubated for
20 min at room temperature. The reactions were run on a 5%
polyacrylamide gel in 0.56 Tris-borate EDTA buffer at 250 V
for 2 h. Gels were dried and exposed to a PhosphorImager
screen (Molecular Dynamics), scanned on a Storm 860 scanner
(Amersham), and band density was quantified using
ImageQuant software v5.2 (Amersham).
Immunoblotting
Immunoblots were performed as described previously
(Azarian et al., 1993) with a few modifications. Whole brain
lysates (60 mg/lane) from 129B6 and DBA/2J mice were used
in the assay. Protein concentration was quantified using a
BCA (bicinchoninic acid) protein assay (Pierce). The following
antibodies were utilized to detect specific antigens.
Polyclonal antibodies developed in rabbit, anti-BAX antibody
(B3428) and anti-actin antibody (A2066) were purchased
from Sigma and used at 1:2000 and 1:100 dilutions
respectively. The secondary antibody was alkaline-phospha-
tase-conjugated and the blot was visualized utilizing ECF
Substrate (Amersham Biosciences). Blots were scanned on a
Storm 860 scanner (Amersham), and band density quantified
using ImageQuant software v5.2 (Amersham).
Quantitative analysis of BCL-X and BAX protein levels were
examined using blot strips. Equal protein amounts of retinal
lysates were each run in single oversized lanes on 12%
polyacrylamide gels. After transblotting to Immobilon-P mem-
branes, each lane was divided into three equal-sized strips, and
eachstripwasindividuallyprobedwithpolyclonalantibodiesfor
actin, BAX or BCL-X (sc-634, Santa Cruz Biotechnology, Santa
Cruz, CA, U.S.A.; 1:1000 dilution). After probing with secondary
antibody, the blots were developed using colorimetric staining
for alkaline phosphatase activity in Nitro-Blue Tetrazolium and
BCIP (5-bromo-4-chloroindol-3-yl phosphate). Staining for
BCL-X and BAX was allowed to continue until one of the
comparative strips had reached saturation.
In silico analysis
The 10 bp core sequence from the 129B6 Bax promoter,
AGGTTTGCCT, was entered as a search term in a number
of different transcription factor databases all available
online: JASPAR (http://mordor.cgb.ki.se/cgi-bin/jaspar2005/
jaspar_db.pl), TESS (http://www.cbil.upenn.edu/cgi-bin/tess/
tess), TFSearch (http://www.cbrc.jp/research/db/TFSEARCH.
html) and MatInspector from Genomatix (http://www.
genomatix.de). For the initial screen of transcription factors
putatively binding to the core sequence, any sequence not
possessing at least 60% homology with the core was eliminated.
Other parameters taken into account were transcription-factor-
binding sequences that matched a portion of the core sequence,
including the polymorphic site, with high sequence similarity
and in the correct succession of base pairs. The likelihood of that
particular transcription factor being expressed in mouse neurons
was also considered.
Statistical analyses
For data presented as means¡S.E.M., assessment for
significant differences between groups was performed by
Student’s t test. The data from quantified EMSA gels were
plotted, best-fit curves generated, and IC50 values were
calculated using Kaleidagraph 4 software (Synergy Software).
RESULTS
Genetically distinct mice, heterozygous for
mutant Bax, display susceptible or resistant RGC
death phenotypes in response to ONC
ONC in mice causes the selective death of RGCs that generally
progresses to maximal cell loss by 3 weeks after surgery in
wild-type animals (Li et al., 1999; Li et al., 2007). We initially
investigated the effects of Bax gene dosage on RGC survival in
129B6 mice and DBA/2J miceat an intermediate termperiod (2
weeks) after ONC (Figure 1A). DBA/2J
Bax+/+ mice had 66% cells
remaining, which represents a loss of 34.0¡2.45% of the cells
in the ganglion cell layer relative to the control retina
(P,0.001). Likewise, 129B6
Bax+/+ mice had 62.3% of their cells
remaining, or a loss of 37.7¡5.3% of the cells in the ganglion
cell layer relative to control retinas (P,0.005). DBA/2J
Bax2/2
and 129B6
Bax2/2 were completely resistant to the damaging
effects of ONC (P.0.25 for DBA/2J
Bax2/2, P.0.10 for
129B6
Bax2/2 relative to control). Importantly, animals hetero-
zygous for Bax exhibited distinctly different phenotypes.
129B6
Bax+/2 mice displayed significant cell death after ONC
(P,0.005), similar to wild-type animals. DBA/2J
Bax+/2
displayed no significant cell death (P.0.25), similar to
Bax
2/2 animals. The results observed for 129B6
Bax+/2 and
DBA/2J
Bax+/2 were consistent with previously published
reports of cell death after acute nerve trauma in these two
lines (Deckwerth et al., 1996; Libby et al., 2005a). In order
to examine if there was long-term protection of RGCs in
Bax
+/2 mice, experiments examining RGC loss in resistant
DBA/2J
Bax+/2 mice at both 3 and 8 weeks post-ONC were
performed (Figures 1B–1G). Mice at 3 weeks after ONC still
SJ Semaan, Y Li and RW Nickells
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(A)Histogramsofthemean¡S.E.M.cellsremainingintheretinalganglioncelllayer2weeksafterONCinDBA/2Jand129B6mice. Both
129B6
Bax2/2 and DBA/2J
Bax2/2 mice showed no significant loss of cells relative to control eyes (P.0.10 and P.0.25 respectively),
whereas wild-type mice showed significant loss (P,0.005). DBA/2J
Bax+/2 mice displayed a knockout phenotype, showing no significant
loss (**P.0.25), whereas 129B6
Bax+/2 exhibited significant cell loss similar to wild-type animals (*P,0.001). After a prolonged period
after ONC, however, resistant heterozygous mice also exhibit cell loss. (B–F) Nissl-stained cells in the ganglion cell layer of whole
mounted mouse retinas. A region of approx. 10
4 mm
2 of the superior mid-peripheral retina of each eye is shown. (B) Control retina from
a Bax
+/2 mouse. (C) Retina from a Bax
+/2 mouse, 3 weeks after ONC. Minimal cell loss is observed, compared with control. (D) Retina
from a Bax
+/2 mouse, 8 weeks after ONC. These mice exhibit moderate cell loss and partial atrophy, typified by cell soma shrinkage of
the remaining ganglion cell population, which is common in Bax-deficient neurons after damage (Li et al., 2000; Sun and Oppenheim,
2003). (E) Retina froma Bax
+/+ mouse, 3 weeks after ONC. Thesemicetypically exhibit a maximumloss of ganglion cells by thisstage. A
cell undergoing apoptosis is indicated by the arrow. (F) Retina from a Bax
2/2 mouse, 18 months after ONC. Even at this extended time
after a lesion to the nerve, there is minimal loss of cells in the ganglion cell layer. Note that Bax
2/2 animals have a higher density of
ganglioncells thaneitherwild-typeorheterozygous micebecauseofthelackofBax-dependentprogrammedcelldeath,whichnormally
prunes approx. 50% of the ganglion cell population during the first few weeks of life (Mosinger Ogilvie et al., 1998; Pequignot et al.,
2003). Scale bar, 15 mm. (G) Quantitative analysis of the change in cell numbers in experimental retinas 3 weeks, 8 weeks and 18
months after ONC. Results are presented as a percentage of cells (means¡S.E.M.) counted in the control fellow eyes of all mice
examined. Bax heterozygous animals were on the DBA/2J background, whereas Bax
2/2 mice were on the 129B6 background for this
experiment. A total of five to seven mice were analysed for each condition, except for Bax
2/2 mice at 18 months, in which two mice
were examined. (*P52.85610
26 and **P57.78610
218, both compared with control fellow eyes of mice used in each group).
Bax-dependent ganglion cell death
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91showed dramatic preservation of cells in the ganglion cell layer
(,90% of control retinas), but a significant loss of cells by 8
weeks (72.3¡3.4% cells remaining, P52.85610
26). This loss of
cells was still well below that for Bax
+/+ mice at 3 weeks, which
exhibitedonly45.8¡1.7% of the cellspresent in control retinas,
and probably accounts for complete elimination of the RGC
population in this retinal layer. Conversely, Bax
2/2 RGC somas
survive up to 18 months after optic nerve damage, exhibiting
more than 92% cells remaining at that point.
DBA/2J
Bax+/2 and 129B6
Bax+/2 mice express
different neuronal levels of Bax
We then examined if the variation in susceptibilities between
heterozygous DBA/2J and 129B6 mice was either due to a
difference in BAX protein function caused by an amino acid
substitution or the level of expression. Sequence analysis of
cDNAs isolated from the DBA/2J and 129B6 strains yielded no
difference in predicted amino acid structure (data not shown).
This ruled out the possibility that a difference in BAX protein
function as a consequence of an amino acid sequence
difference was the underlying cause of the phenotype. We
then investigated whether there was a difference in neuronal
Bax expression. Quantitative PCR was used to quantify Bax
mRNA levels in the retinas of 129B6 and DBA/2J mice
(Figure 2A). As the number of RGCs that populate the ganglion
cell layer in DBA/2Jand 129B6 retinas arecomparable, and Bax
mRNA has been shown to be principally localized to the RGC
layer of adult rats (Shin et al., 1999), we used whole retinal
cDNA for analysis. In each strain, neuronal Bax mRNA levels
were reduced by approx. 50% in heterozygous mice relative to
wild-type mice. Bax
2/2 mice of either strain expressed no
detectable Bax mRNA. Retinas from 129B6 mice contained
twice the level of Bax mRNA compared with DBA/2J mice, such
that 129B6
Bax+/2 and DBA/2J
Bax+/+ animals had similar levels
of Bax transcripts (P50.46) (Figure 2A). Consistent with the
mRNA levels, 129B6
Bax+/+ neurons expressed 1.2- to 1.8-fold
(range for three separate experiments) the BAX protein level as
DBA/2J
Bax+/+ neurons (Figure 2B). Similarly, BAX protein
measurements indicated that 129B6
Bax+/2 neurons had
between 1.4- and 2.0-fold (range for three separate experi-
ments) the amount of BAX protein as DBA/2J
Bax+/2 neurons.
Bax
2/2 mice expressed no detectable BAX protein (Figure 2B).
These observations correlated the higher susceptibility to ONC
observed in 129B6
+/2 mice (Figure 1A) with latent levels of
Bax mRNA and protein.
Even though the lower levels of latent Bax mRNA and
protein in DBA/2J mice were associated with resistance to
ONC in heterozygous animals, we investigated if other factors
may also be affecting this phenotype. Since cell death is
influenced in a stoichiometric fashion by the levels of anti-
apoptotic and BH3-only members of the Bcl2 gene family, we
also examined mouse retinas for the expression of antagon-
istic anti-apoptotic genes. Previously, we had described BclX
as the dominant anti-apoptotic Bcl2 family member
expressed in the retina (Levin et al., 1997). No significant
difference in BclX transcript level was observed between
Bax
+/+ and Bax
2/2 of each strain (data not shown).
Importantly, there was no significant difference in BclX
transcript levels between 129B6
Bax+/2 and DBA/2J
Bax+/2
(P50.26, Figure 2C). Furthermore, in direct quantitative
analyses of the same tissues, BclX transcripts were also 5–
10-fold more abundant than Bax transcripts (compare
Figure 2A with Figure 2C). To verify that there was also in
increased level of BCL-X protein, predicted by the mRNA
levels, we examined relative BCL-X and BAX protein
concentrations in retina homogenates of wild-type 129B6
and DBA/2J mice. Strips cut from the same lanes of sample
run on SDS/12% polyacrylamide gels were individually probed
with antibodies against BCL-X, BAX and actin (to control
for loading differences). Strips developed for equal periods
of time for BCL-X and BAX showed a strong reaction for
BCL-X, but BAX levels were only just detectable (Figure 2D).
Thus, BCL-X protein levels appeared to be in excess over
BAX in both samples, consistent with the quantitative PCR
data.
Some studies have suggested that Bax expression is
increased in RGCs after optic nerve damage (Isenmann et
al., 1997; Na ¨pa ¨nkangas et al., 2003). Although this increase in
expression has been refuted by others (McKinnon et al.,
2002), we nevertheless explored the possibility that Bax
was differentially up-regulated after crush in the two mouse
lines. Quantitative analysis of Bax transcript levels in
mouse retinas 4 days after ONC indicated that Bax mRNA
levels were not induced in the retina (Figure 2E). Instead, each
strain exhibited a significant decrease in transcript abundance
(DBA/2J Control compared with 129B6 Control, P52610
24;
DBA/2J Control compared with DBA/2J Crush, P50.003; 129B6
Control compared with 129B6 Crush, P51610
24).
A single-nucleotide polymorphism in the Bax
gene promoter is associated with a decrease in
transcriptional activity
To investigate the mechanism underlying differential Bax
expression, we examined the promoter regions for differences
in cis-element sequences. For this, we cloned 1370 bp of the
Bax promoter regions directly upstream of the translation
start site from the DBA/2J and 129B6 mouse lines and
compared them by sequence analysis. Both promoters were
identical with the exception of a single T (in 129B6) to a C (in
DBA/2J) polymorphism at position 2515 upstream from the
start of translation (Figure 3). This polymorphism was verified
in six independent mice of each strain. Analysis of potential
binding sites in this region showed that the polymorphism
existed within a potential p53 half-site in the DBA/2J line. We
tested the ability of this polymorphism to affect transcription
in vitro by fusing 1370 bp of the promoter region of each
strain to a Luc reporter gene. Transient transfection
experiments into both non-neuronal NIH 3T3 cells and
RGC-derived RGC-5 cells showed that 129B6–Luc consistently
exhibited 1.5-fold the expression level of DBA/2J–Luc in
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24and P51.71610
212 respectively,
Figure 4). Transient transfections into primary fibroblasts isolated
from DBA/2J and FVB mice showed 129B6–Luc expression to
be 2.5- and 2.3-fold higher than DBA/2J–Luc expression
(P50.002 and P52.82610
26 respectively), which was similar
to the difference in Bax transcript levels between 129B6 and
DBA/2J mice. Thus the higher expression observed in vitro
from 129B6–Luc suggested that this polymorphism was, at least
in part, responsible for the difference in Bax expression observed
in vivo.
The difference in the level of expression between
DBA/2J–Luc and 129B6–Luc is not regulated by
p53
We first determined if nuclear proteins interacted with the
polymorphic site. EMSAs were performed using radiolabelled
129B6 or DBA/2J probes spanning 30 bp, including the
polymorphic site (see Figure 3), and nuclear extracts isolated
from NIH 3T3 cells or retinal tissue. Retinal nuclear extracts
were derived from either 129B6 or DBA/2J mice, both yielding
Figure 2 DBA/2J and 129B6 mice differentially express Bax
(A) Quantitative PCR analysis of latent Bax transcript levels (means¡SEM)in 129B6 and DBA/2J mice. Values shown are the number of
Bax mRNA molecules [per 2.5 pg of poly(A) RNA input] normalized to the number of S16 molecules in each sample. Reducing Bax gene
dosage to one gene caused a 50% reduction of Bax transcripts (for 129B6, P50.004, for DBA/2J, P50.002, control retinas of Bax
+/2
mice compared with control retinas of Bax
+/+ mice) and no transcripts were detected in knock-out mice. Similarly, 129B6 mice had
approximately twice the amount of Bax mRNA in the retina (*129B6
Bax+/+ compared with DBA/2J
Bax+/+ mice, P50.008; **129B6
Bax+/2
compared with DBA/2J
Bax+/2 mice, P50.002). (B) Representative immunoblot showing relative Bax protein levels in DBA/2J and 129B6
neurons. Bax protein levels were 1.2- to 1.8-fold higher in 129B6
Bax+/+ mice compared with DBA/2J
Bax+/+ mice (when normalized to
actin in each lane). Similarly, 129B6
Bax+/2 mice expressed 1.4- to 2.0-fold as much Bax as DBA/2J
Bax+/2 mice. No Bax protein was
detected in Bax
2/2 mice. (C) Histogram of BclX transcript levels in the retinas of Bax heterozygous mice from each strain. Unlike Bax
mRNA, no difference in BclX mRNA was detected between strains (P50.26), or between wild-type and knockoutmice (data notshown).
(D) Blot strips taken from the same lanes of retina homogenates of wild-type DBA/2J or 129B6 mice. To accurately assess the relative
levels of BAX and BCL-X, the strips were developed equally, until BCL-X staining began to saturate the colorimetric reaction. BCL-X
showsupastwoprominentbands, probably reflectingmodifiedanddeamidatedpolypeptides(Johnstone,2002).BAXlevels,underthese
conditions, are just detectable. Chemiluminescence detection of BAX staining clearly shows, however, that this antibody specifically
interacted with BAX protein in similar samples (see B). Actin was also evaluated as a loading control. (E) Histogram showing changes in
Bax transcript abundance (means¡S.E.M.), 4 days after ONC. Retinal transcript levels were examined at 4 days after injury when others
have reported moderate increases in Bax mRNA after optic nerve axotomy (Na ¨pa ¨nkangas et al., 2003). ONC caused a 42.0¡13.2%
decrease in Bax mRNA in DBA/2J mice relative to control eyes (*P50.003) and a 79.0¡3.8% decrease in 129B6 mice relative to
control eyes (**P54.6610
25). The control retinas of 129B6
Bax+/+ mice contained 2.2-fold the amount of Bax mRNA compared with
control DBA/2J
Bax+/+ retinas (P52.0610
24). Thus Bax expression was not differentially increased between strains, and instead showed
a relative decrease after injury.
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93the same result. Only data from the 129B6 extract is shown.
NIH 3T3 and retinal nuclear extract produced two predom-
inant shifted complexes, Complex 1 and Complex 2, compared
with lanes with no nuclear extract (Figure 5). Although
Complex 2 consisted of multiple bands, these bands behaved
similarly in competition assays (data not shown) and were
treated as a single complex during analyses. The polymorph-
ism in the DBA/2J promoter was contained within a consensus
p53 half-site. Two of these p53 half-sites, 0–13 bp apart, are
typically required for effective p53 binding (El-Deiry et al.,
1992). Others have shown, however, that p53 half-sites can
mediate expression, which involved p53 binding, by remotely
interacting with other cis-elements (Menendez et al., 2007).
The change of a T(129B6) to a C(DBA/2J) at the 2515 position
would putatively increase p53 interactions with the DBA/2J
half-site.
We initially tested the hypothesis that binding of p53,
principally to the DBA/2J polymorphism, may be acting to
repress transcription. To examine p53 involvement, unlabelled
competition EMSA was first performed with a 50-fold molar
excess of a concatemer of four p53 half-sites (Figures 6A and
6B). The unlabelled p53 half-site concatemer competed
specifically with Complex 1 (P54.23610
210). This result
was consistent with possible involvement of p53, but
importantly indicated that DNA–protein interactions of
Complex 1 included the polymorphic region. To test the
effects of p53 directly, we transiently transfected DBA/2J–Luc
and 129B6–Luc into primary fibroblasts isolated from p53
2/2
FVB mice, to determine if the differential expression observed
between the two promoters was lost in the absence of p53. In
p53
2/2 fibroblasts, 129B6–Luc expression was approx. 1.5-
fold higher than DBA/2J–Luc (P50.03), and in p53
+/+ cells
129B6–Luc expression was twice as high as DBA/2J–Luc
expression (P50.003, see FVB cells in Figure 4). As a control,
we also co-transfected the cells with a plasmid expressing
exogenous p53 (pC53-SN3). The addition of exogenous
p53 did not significantly transactivate or repress either
DBA/2J–Luc (P50.16, compared with no p53) or 129B6–Luc
(P50.30) expression (Figure 6C). Conversely, a reporter
construct with 13 p53 consensus sites (pG13–Luc) exhibited
8-fold more Luc expression after the addition of exogenous
p53 compared with cells without p53 (P50.0001, Figure 6C).
Importantly, differential expression between DBA/2J–Luc
and 129B6–Luc was not affected by the presence or absence
of p53. In order to confirm these data, we examined if
the EMSA-binding pattern was altered in nuclear extracts
isolated from p53
2/2 cells. Extracts from both p53
+/+ and
p53
2/2 fibroblasts (with an otherwise identical genetic
background) yielded identical EMSA banding patterns,
including Complex 1 (data not shown). Lastly, super-shifting
either complex with a p53 antibody was unsuccessful (data
not shown).
The single nucleotide polymorphism affects the
binding affinity of nuclear proteins
Because p53 was ruled out as a transcription factor that
affected the difference in expression, we determined if the
polymorphism affected the binding affinity of other nuclear
proteins. Competition EMSA was performed to determine
relative binding affinities for the polymorphic site. Complexes
formed on radiolabelled DBA/2J or 129B6 probes were
competed with increasing fold molar excess of either
Figure 3 Diagram of 1370 bp of the murine Bax promoter region
The Bax promoter region from the DBA/2J and 129B6 mouse lines was
isolated, sequenced, and compared. The nucleotide directly upstream of the
translation start site is indicated as 21 in the first exon and numbering of
the murine Bax promoter is relative to this position. Depicted are the
sequences of 30 bp of the 129B6 and DBA/2J promoter regions at positions
2499 to 2528. A single nucleotide polymorphism (outlined with a dashed
box) was found at position 2515. The core p53 half-site recognition
sequence is Pu Pu Pu C A/T A/T G Py Py Py (where Pu, purine; Py, pyramidine)
(El-Deiry et al., 1992). The DBA/2J promoter has a perfect consensus
sequence (underlined). Other putative transcription factor binding sites are
also shown as previously described (Igata et al., 1999).
Figure 4 Expression from 129B6–Luc is higher than DBA/2J–Luc in both
immortalized non-neuronal and neuronal cell lines and primary fibroblasts
DBA/2J–Luc or 129B6–Luc were transiently co-transfected with pSV-bgal
into NIH 3T3 murine fibroblasts, RGC-5 cells, or primary fibroblasts derived
from either DBA/2J mice or FVB mice. The histogram represents the mean Luc
levels (in RLU, relative light units) normalized to bgal activity (¡S.E.M.) of
three to five experiments, with three to six replicates for each condition in
each experiment. 129B6–Luc exhibited 1.5-fold the expression of DBA/2J–
Luc in NIH 3T3 cells and RGC-5 cells (*P53610
24 and **P51.71610
212
respectively). In transient transfections of primary fibroblasts from DBA/2J
and FVB mice, 129B6–Luc exhibited 2.5- and 2.3-fold the expression,
respectively, of DBA/2J–Luc (***P50.002 and ****P52.82610
26 respectively).
These results are consistent with higher levels of Bax mRNA in neurons of
129B6 mice. Cells from 129B6 mice were excluded from this analysis because
they exhibited poor growth kinetics in primary cultures.
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inhibition constants at half the labelled complex formation
(IC50) were calculated using Kaleidagraph software from the
values of band density in each lane. The values were plotted
and a best-fit curve generated (Figure 7A). For Complex 1,
the IC50 value for the DBA/2J radiolabelled probe competed
with unlabelled DBA/2J DNA was 5.07¡0.39 (fold molar
excess) and with unlabelled 129B6 DNA was 1.04¡0.06.
The IC50 for the 129B6 radiolabelled probe compared with
unlabelled DBA/2J DNA was 8.62¡0.35 and compared
with unlabelled 129B6 DNA was 2.47¡0.16 (Figure 7B).
Thus, 4–5-fold more unlabelled DBA/2J DNA, relative to
unlabelled 129B6 DNA, was required to inhibit half of the
radiolabelled complex from each probe. These results
suggested that the protein(s) forming Complex 1 had a
higher affinity for the 129B6 site. For Complex 2, the IC50
value of the DBA/2J radiolabelled probe co-competed with
DBA/2J unlabelled DNA was 180.53¡8.95 and with 129B6
unlabelled DNA was 132.63¡10.91 (Figure 7B). The IC50 for
Complex 2 of the 129B6 radiolabelled probe compared with
the unlabelled DBA/2J DNA was 198.14¡19.45 and compared
with unlabelled 129B6 DNA was 128.57¡10.85 (Figure 7B).
The IC50 ratios of Complex 2 indicated that the protein(s)
forming this complex exhibited similar binding affinities for
both the DBA/2J and 129B6 DNAs. These data indicated
Complex 1 was formed via DNA–protein interactions with the
polymorphic site, whereas Complex 2 was probably formed
with DNA–protein interactions elsewhere on the 30 bp
sequence. To confirm this, we also performed unlabelled
competition EMSA with separate regions of the 30 bp
sequence (Figure 8). Complex 2 formation was inhibited most
successfully with a unlabelled 10 bp DNA fragment upstream
of the polymorphic site, suggesting that this region was
principally involved in Complex 2 formation.
DISCUSSION
Several neuronal populations require Bax for cell death
during development. Bax deficiency resulted in an increase in
neuronal numbers in regions such as the cerebellum,
hippocampus and retina (Mosinger Ogilvie et al., 1998;
White et al., 1998). Importantly, Bax gene dosage was shown
to be critical for susceptibility to RGC death in the DBA/2J
mouse glaucoma model and after ONC (Libby et al., 2005a).
Similarly, we demonstrated that retinal ganglion cell somas
of DBA/2J mice heterozygous for the mutant Bax allele
exhibited resistance to cell death in response to an acute
crush lesion of the optic nerve, when assayed at 2 weeks after
ONC. Unlike completely Bax-deficient cells, which exhibit
essentially permanent resistance to optic nerve lesion, Bax
+/2
cells, which have short-term resistance to ONC (at 2 weeks),
eventually die over a much longer time frame. A distinct cell
death phenotype was observed for Bax
+/2 mice on the 129B6
background, however, in that these ganglion cells died with
similar kinetics to wild-type cells.
Figure 5 Both NIH 3T3 and retinal nuclear extracts produced two shifted complexes in EMSA
A representative PhosphorImager-generated autoradiograph of an EMSA performed with
32P-labelled 129B6 or DBA/2J double-
stranded probe (2499 to 2528 sequence in Figure 3) is shown. No shifted complexes were formed in the absence of nuclear extract.
Nuclear extracts from both fibroblasts and 129B6 retinal tissue (5 mg of total protein each) formed two shifted complexes denoted as
Complex 1 and Complex 2. Three separate extracts, from each tissue source, are shown.
Bax-dependent ganglion cell death
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95The variation in cell death phenotype associated with Bax
genotype appeared to be related to the relative level of latent
Bax mRNA and protein in affected cells. Quantitative analysis
of Bax transcript and protein levels showed that 129B6
neuronal populations (including retina and brain) expressed
approximately twice the level of gene product than did
equivalentcellsofDBA/2Jmice. Importantly,129B6
Bax+/2mice
expressed approximately the same amount of Bax mRNA and
protein as wild-type DBA/2J animals, thus providing one
explanationforwhyanimals of both these genotypesexhibited
essentiallynormallevelsofganglioncell death. Takingthelevel
of Bax expression in these mice as a starting point, two
important observations are made with respect to the level of
Bax and the ability of these neurons to execute apoptosis.
Lowering Bax expression levels by half from this point, as was
observed in DBA/2J
Bax+/2 mice, was a sufficient reduction in
BAX to make ganglion cells substantially resistant to ONC, at
least in the short term. Conversely, doubling Bax expression
levels from the same point, as was observed in 129B6
Bax+/+
mice, had no increased effect on the rate of cell death. This
latter observation is consistent with earlier reports that
transgenic mice overexpressing wild-type Bax showed no
increase in normal developmental programmed cell death
(Bernard et al., 1998), and underscores a hypothetical concept
that cells require a set threshold of Bax expression, which
allows them to completely commit to the apoptotic program
once it has been activated. This threshold may also be distinct
from the levels of other members of the Bcl2 gene family. Both
lines of mice, regardless of Bax genotype, expressed equivalent
levelsofBclXmRNAandprotein,which,atthemRNA level,was
also in approx. 5–10-fold molar excess. Similarly, preliminary
experiments to quantify Bim transcripts, which encode a
principal BH3-only protein involved in ganglion cell death
(Na ¨pa ¨nkangas et al., 2003; McKernan and Cotter, 2007) also
showed no difference between strains (data not shown). Thus
the correlation between cell death and Bax genotype appears
to be mediated primarily by the level of Bax expression and not
in conjunctionwith altered levels of othermembersof theBcl2
gene family.
A caveat to the conclusion that lower Bax expression levels
influence retinal ganglion cell in DBA/2J mice is that there
are probably multiple interacting genes that influence the
cell death response. These genes could also vary between
Figure 6 p53 does not regulate differential expression of the Bax promoter
(A) PhosphorImager-generated autoradiograph of a competition EMSA using
the 129B6 probe and 129B6 retina extract. In order to test possible p53
involvement, unlabelled competition EMSA was performed with a 50-fold
molar excess of a concatemer of four p53 half-sites and compared with the
DBA/2J and 129B6 unlabelled competitors at a 50-fold molar excess
(consisting of the 30 bp highlighted in Figure 3). The unlabelled p53 half-site
concatemer competed specifically with Complex 1, whereas DBA/2J and
129B6 oligos competed with both Complexes. NC, lane containing no
competitor. (B) Histogram showing quantification of percentage inhibition of
Complex 1 and 2 formation compared with NC (means¡SEM). The amount of
complexed probe in the presence of no competitor DNA was assigned a value
of 100% and subsequent competitor lanes are expressed as a percentage of
this. The p53 consensus sequence, DBA/2J sequence and 129B6 sequence all
significantly competed Complex 1 (*P,0.01; P54.23610
210, P55.176
10
28 and P52.13610
210 respectively compared with NC. The p53
consensus sequence did not significantly compete Complex 2 (P50.45),
whereas the DBA/2J and 129B6 sequences did (**P,0.01; P56.29610
25
and P51.10610
25 respectively). (C) Histogram of Luc activity in transient
transfections of p53
2/2 fibroblasts (FVB mice). Bax–Luc constructs were co-
transfected with pSV-bgal and either pGL-Basic (-p53) or pC53-SN3 (+p53).
The 129B6–Luc construct had higher expression than the DBA/2J–Luc
construct with or without addition of exogenous p53 (P50.03 and P50.006,
respectively). Although there was a trend toward an increase in expression
from DBA/2J–Luc and 129B6–Luc when co-transfected with human p53,
compared with p53
2/2 cells transfected with a non-expressing control
vector, the increase was not statistically significant (DBA/2J, P50.16; 129B6,
P50.30). These results are consistent with other reports showing that p53
does not transactivate the murine Bax promoter (Igata et al., 1999; Schmidt
et al., 1999; Thornborrow et al., 2002). The p53-responsive vector, pG13–Luc,
exhibited a significant increase in expression with co-transfection of human
p53 (P50.0001), indicating that the exogenous p53 was biologically active in
these cells.
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(A) Representative PhosphorImager-generated autoradiographs of unlabelled co-competition experiments. Top two panels: 600000
c.p.m./lane (0.12 pmol) of radiolabelled DBA/2J probe (left panel) or radiolabelled 129B6 probe (right panel) were reacted with either
no or 5 mg of 129B6 retinal nuclear extract. Complexes were also incubated with no competitor DNA (NC) or increasing molar excess
of unlabelled DBA/2J competitor DNA. Increasing molar excess caused inhibition of the formation of radiolabelled Complex 1 and
Complex 2 compared with lanes with no competitor DNA. Bottom two panels: same probes as the top two panels with increasing
amounts of unlabelled 129B6 competitor DNA. (B) Graphs plotting fold molar excess of DNA compared with band density of
Bax-dependent ganglion cell death
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97different genetic backgrounds. For example, previously we
reported that DBA/2J mice were more resistant to ONC than
BALB/cByJ mice (Li et al., 2007). The difference in phenotype
between the strains accounted for approx. 12% of the
variance found in the loss of RGCs among mice after this
procedure. Examination of the levels of Bax expression
between strains showed that Bax was not the affecting allele,
which was later attributed to a quantitative trait locus that
mapped to chromosome 5 (Dietz et al., 2008). Interestingly,
wild-type C57BL/6J and 12961/SvJ, which both contribute
to the genetic make-up of129B6 mice, exhibited a cell death
phenotype statistically similar to DBA/2J mice. This suggests
that influences attributable to different genetic background
are not dramatically influencing the relationship between
Bax expression and cell death we observed in the present
study.
Experiments described in the present study establish a link
between a single nucleotide polymorphism in the Bax
promoter with the quantitative difference in Bax expression
observed between the DBA/2J and 129B6 mouse lines. In
transient transfection experiments, the 129B6 polymorphism
roughly doubled the transcriptional activity of a Luc reporter
gene. It is likely, however, that this cis-element is not the only
factor affecting Bax gene expression quantitatively. Recently,
for example, Whitney et al. (2009) described a quantitative and
hereditary difference in amacrine cell number in the retinas of
C57BL/6J and A/J mice. This quantitative trait was mapped to a
locus on chromosome 7, near Bax, and was associated with a
higher level of Bax transcripts in A/J mice. Surprisingly, A/J
mice carry the 2515(C) polymorphism, similar to DBA/2J mice,
whereas C57BL/6J mice carry the 2515(T) polymorphism,
which is the opposite association of what we would predict
from our data presented here. Although no in vitro
transcription studies were conducted by this group, they
hypothesized that differential transcription of the Bax allele
may be due to enhanced p53 binding to the A/J allele. Since
our studies have excluded p53 binding to this region, we
predict that differences in genetic background can influence
Bax transcription both at the level of the cis-element
polymorphism and the transcriptional machinery interacting
withit.Overall, ourstudies,combinedwith those ofWhitney et
al. (2009), underscore the importance of characterizing the
transcription factors interacting with this polymorphic site.
Candidates for transcription factors that may interact with
this site were examined. Although the polymorphism in the
DBA/2J Bax promoter creates a perfect consensus p53 half-
site (El-Deiry et al., 1992), our experiments clearly exclude
p53 binding as a critical factor for the differential regulation
of Bax. We then investigated if the affinity of other nuclear
proteins was affected by the polymorphism. Our data
suggested that the polymorphism in the Bax promoter was
sufficient to cause a difference in binding affinity of nuclear
proteins. Specifically, nuclear proteins were found to be
Figure 8 Complex 2 is formed by DNA–protein interactions involving
nucleotides upstream of the polymorphic site
(A) Shown is the 30 bp sequence delineating unlabelled competitor DNAs for
the 129B6 polymorphic region. The polymorphic site is denoted by an asterisk.
Fragments a, b and c span the individual regions shown. These fragments
were used for competition as concatemers of three copies of each 10 bp
region. (B) Representative PhosphorImager-generated autoradiograph of
unlabelled co-competition experiments with different competitor DNAs
reacting with 129B6 retinal extract. The radiolabelled 129B6 full-length
probe was incubated in the presence or absence of unlabelled competitor
DNAs. Each competitor DNA was used at a 150-fold molar excess of potential
binding sites. Competitor a specifically competed Complex 2, while b
competed Complex 1, but minimally competed Complex 2. Alternatively, oligo
bc efficiently competed Complex 2. These results suggested Complex 2 was
formed with interactions upstream of the polymorphic site, but may also
involve interactions further downstream of this site.
complexed probe obtained from analysing PhosphorImager-generated autoradiographs using ImageQuant v5.2 software.
Kaleidograph software was then used to generate graphs and calculate IC50 values. The mean (¡S.E.M.) complex formed in
three separate experiments are shown. The amount of complexed probe in the presence of no competitor DNA was assigned a value
of 100% and subsequent competitor lanes are expressed as a percentage of this. As the fold molar excess competitor DNA increases,
there is increased inhibition of radiolabelled complex formation. Top panels: radiolabelled DBA/2J probe (left) or radiolabelled 129B6
probe (right) compared with increasing fold molar excess of DBA/2J or 129B6 unlabelled competitor DNA for Complex 1. For Complex
1, the IC50 value of DBA/2J radiolabelled probe (left) co-competed with unlabelled DBA/2J DNA was 5.07¡0.39 and with unlabelled
129B6 DNA was 1.04¡0.06. The IC50 for 129B6 radiolabelled probe (right) compared with unlabelled DBA/2J DNA was 8.62¡0.35
and compared with unlabelled 129B6 DNA was 2.47¡0.16. Approx. 4–5-fold more DBA/2J unlabelled DNA relative to unlabelled
129B6 DNA was required to inhibit half of the radiolabelled complex. These data suggest that the protein(s) forming Complex 1 have
a higher affinity for the 129B6 site. Bottom panels: radiolabelled DBA/2J probe (left) or radiolabelled 129B6 probe (right) versus
increasing fold molar excess of DBA/2J or 129B6 unlabelled competitor DNA for Complex 2. The IC50 value of the DBA/2J
radiolabelled probe (left) co-competed with DBA/2J unlabelled DNA was 180.53¡8.95 and with 129B6 unlabelled DNA was
132.63¡10.91. The IC50 for Complex 2 of the 129B6 radiolabelled probe (right) compared with unlabelled DBA/2J DNA was
198.14¡19.45 and compared with unlabelled 129B6 DNA was 128.57¡10.85. The IC50 ratios of Complex 2 indicate that the
protein(s) forming this complex exhibit similar binding affinities for both the DBA/2J and 129B6 DNAs.
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Therefore, we predicted that an activator or an activation
complex was interacting more efficiently with the 129B6
promoter, resulting in an increase in transcription. The
identities of the binding proteins in this region are currently
being investigated. Interestingly, artificial transcription
factors have been designed to bind to a p53 half-site
contained in the human BAX promoter with the intention of
selectively up-regulating BAX and not other p53 targets
(Falke et al., 2003). An artificial transcription factor contain-
ing five zinc-finger-binding motifs, 5ZFAV, was able to elicit
significant transactivation from a 40 bp section of promoter
containing the consensus p53 half-site. A caveat to this
study, however, was that this portion of the promoter also
contained three other imperfect p53 half-sites, which could
have affected binding and therefore may not be analogous to
the mouse polymorphic region.
Alternatively, a search of several transcription-factor-
binding-site databases, using the consensus 10 bp surround-
ing the 129B6 polymorphism, identified other potential
transcription factor-binding sites (Table 1). None of the sites
was a perfect match. Nevertheless, the putative transcription
factors identified were activators of transcription, consistent
with our prediction that Complex 1 is a positive regulator of
transcription. These potential transcription factors included
C/EBP (CCAAT/enhancer-binding protein), FOXI1 (Forkhead
box I1), and E2F1. E2F1 may be the most promising candidate
because of the role it plays in apoptosis. Mice deficient in
E2F1, for example, have excess T-cells owing to defects in
thymocyte apoptosis, and E2F1 has been shown to activate
the expression of Apaf-1. Importantly, increased E2F1 activity
also resulted in the release of cytochrome c (Ginsberg, 2002).
In microarrays, E2Fs have also been implicated in the up-
regulation of members of the Bcl-2 gene family, including
Bad and Bak (Ma et al., 2002).
Although experimentally we have demonstrated that the
level of Bax expression can profoundly affect cell death, we
have only been able to detect this phenotype in mice that have
beengeneticallymanipulated to have onefunctional Bax gene.
Interestingly, however, a similar phenotype has been described
in humans. Saxena et al. (2002) noted that patients with
chronic lymphocytic leukaemia had a high BCL2/BAX protein
ratio. Further examination revealed that a single G to an A
polymorphism 248 bp upstream from the translational start
site was present in one copy of the BAX gene of 69% of the
patients. This promoter polymorphism associated with late-
stage disease and resistance to treatment. These investigators
then demonstrated that this polymorphism was responsible for
a 2.6-fold reduction in BAX expression (Moshynska et al.,
2005). Although the G(2248)A polymorphism in the human
BAX promoter lies outside of the polymorphism we have
detected in the mouse Bax promoter, these observations
validate the concept that mutations affecting BAX expression
can influence cell death in disease. Based on our observations
in mice, the same or similar polymorphisms in the human BAX
genemay also contributetosusceptibility ofcellsin genetically
complex neurodegenerative diseases.
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